Personalized Weight Loss: Why Your Response May Differ The PlexusDx Precision Peptide Genetic Test analyzes GLP1R, and FTO variants that relate to GLP-1 and related signaling pathways
Key Clinical Applications 1
Because GHK-Cu arrives as lyophilized powder reconstituted to a researcher-chosen concentration, the same target dose corresponds to different syringe volumes depending on the reconstitution choice
How PlexusDx Supports a More Personalized Approach PlexusDx's Precision Peptide Genetic Test may help provide context by identifying predispositions in GLP-1 receptor (GLP1R rs6923761) and related metabolic genes (GIPR, FTO, MC4R variants)
Oxford: Elsevier (2015)
Similarly, research in Cell Death and Disease (2017) demonstrated that spermidine treatment reduced weight gain, decreased visceral fat, and improved glucose tolerance and insulin sensitivity in mice fed a high-fat diet, thanks to the induction of autophagy